<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00350506</url>
  </required_header>
  <id_info>
    <org_study_id>VCT-001</org_study_id>
    <nct_id>NCT00350506</nct_id>
  </id_info>
  <brief_title>A Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT</brief_title>
  <official_title>An Open-label, Non-randomized, Multi-center Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <brief_summary>
    <textblock>
      To compare computed tomography (CT) images (pictures) of the coronary arteries using the
      General Electric (GE) LightSpeed VCT scanner with x-ray coronary angiography in patients
      referred for an x-ray coronary angiography.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sponsor decision (due to low subject enrollment)
  </why_stopped>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">October 2006</completion_date>
  <primary_completion_date type="Actual">October 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">77</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>64 Channel VCT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed by catheter coronary angiography (CATH).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>64 Channel VCT</intervention_name>
    <arm_group_label>64 Channel VCT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective diagnostic catheterization OR

          -  Elective diagnostic catheterization has been performed within the past 2 weeks but no
             less than 24 hours prior to the coronary CTA procedure with no intervention performed
             or change of the patient clinical status.

          -  Age ≥18 years but ≤75 years.

        Exclusion Criteria:

          -  Prior coronary stent implantation

          -  Prior coronary artery bypass grafting or other heart surgery

          -  Prior pacemaker or internal defibrillator lead implantation

          -  Prior artificial heart valve

          -  Biochemical renal insufficiency (CrSerum &gt; 1.6) or on dialysis

          -  Resting HR &gt; 100 at the time of enrollment

          -  Contraindication to β-blockade or calcium channel blocker

               -  NYHA-IV

               -  High-grade atrioventricular (AV) block

               -  Systolic blood pressure &lt;90 mm Hg

               -  Severe asthma or active bronchospasm and/or chronic obstructive pulmonary disease

          -  Atrial fibrillation

          -  Inability to provide informed consent

          -  Evidence of ongoing or active clinical instability

               -  Acute chest pain (sudden onset)

               -  Acute myocardial infarction

               -  Cardiac shock

               -  Acute pulmonary edema
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Centofanti, MS</last_name>
    <role>Study Director</role>
    <affiliation>GE Healthcare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GE Healthcare</name>
      <address>
        <city>Princeton</city>
        <state>New Jersey</state>
        <zip>08540</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 6, 2006</study_first_submitted>
  <study_first_submitted_qc>July 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 10, 2006</study_first_posted>
  <last_update_submitted>April 26, 2019</last_update_submitted>
  <last_update_submitted_qc>April 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

